Ad
related to: sellas life sciences stock forecast this week today- Planning for Retirement?
Boost to Your Retirement Plan
The 5 Best Stocks for Retirees
- Chipmaker Set to Soar Now
Best 2024 Semiconductor Stock?
One Chipmaker Worth Buying Now
- Anti-Gold Investor Guide
Investments to buy instead of gold
Free guide to protect your wealth
- Free: Invest Like Buffett
5 "Buffett stocks" to buy right now
New report names 5 wealth-builders
- Planning for Retirement?
Search results
Results From The WOW.Com Content Network
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In ...
GenFleet Therapeutics has granted GFH009 rights to SELLAS Life Sciences Group Inc (NASDAQ: SLS) across all therapeutic and diagnostic uses worldwide outside of Greater China (mainland China, Hong ...
For premium support please call: 800-290-4726 more ways to reach us
In 2017, Galena Biopharma Inc. announced a merger "with privately-held oncology company Sellas Life Sciences Group Ltd. in an all-stock transaction." [47] The combined company was Sellas Life Science Group. The newly merged companies focused on the development of novel treatments for cancer. [48]
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Life Sciences: Operates laboratories specialising in environmental monitoring, food and pharmaceutical, electronics, and consumer products market sectors. Commodities: Provides testing services for the global mining industry in service areas such as geochemistry , metallurgy , coal , mine site services and inspection.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) announced topline data from its Phase 1/2 trial of galinpepimut-S (GPS) in WT1(+) relapsed or refractory platinum-resistant advanced metastatic ovarian ...
Ad
related to: sellas life sciences stock forecast this week today